Free Trial

BrainsWay (BWAY) Competitors

BrainsWay logo
$9.83 +0.16 (+1.65%)
(As of 11/20/2024 ET)

BWAY vs. XAIR, DCTH, APEN, KIDS, AXGN, SIBN, TMCI, CATX, TCMD, and ZIMV

Should you be buying BrainsWay stock or one of its competitors? The main competitors of BrainsWay include Beyond Air (XAIR), Delcath Systems (DCTH), Apollo Endosurgery (APEN), OrthoPediatrics (KIDS), AxoGen (AXGN), SI-BONE (SIBN), Treace Medical Concepts (TMCI), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), and ZimVie (ZIMV). These companies are all part of the "medical" sector.

BrainsWay vs.

Beyond Air (NASDAQ:XAIR) and BrainsWay (NASDAQ:BWAY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability, community ranking and analyst recommendations.

BrainsWay received 20 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 66.67% of users gave BrainsWay an outperform vote.

CompanyUnderperformOutperform
Beyond AirOutperform Votes
48
69.57%
Underperform Votes
21
30.43%
BrainsWayOutperform Votes
68
66.67%
Underperform Votes
34
33.33%

Beyond Air currently has a consensus target price of $3.67, indicating a potential upside of 645.86%. BrainsWay has a consensus target price of $13.17, indicating a potential upside of 33.94%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than BrainsWay.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beyond Air
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
BrainsWay
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Beyond Air has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500. Comparatively, BrainsWay has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

BrainsWay has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beyond Air$1.16M30.59-$60.24M-$1.41-0.35
BrainsWay$31.78M5.16-$4.20M$0.1098.31

BrainsWay has a net margin of 3.88% compared to Beyond Air's net margin of -2,369.17%. BrainsWay's return on equity of 3.52% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
Beyond Air-2,369.17% -227.29% -106.51%
BrainsWay 3.88%3.52%2.26%

In the previous week, BrainsWay had 8 more articles in the media than Beyond Air. MarketBeat recorded 15 mentions for BrainsWay and 7 mentions for Beyond Air. BrainsWay's average media sentiment score of 0.89 beat Beyond Air's score of 0.55 indicating that BrainsWay is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beyond Air
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
BrainsWay
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 30.1% of BrainsWay shares are owned by institutional investors. 20.1% of Beyond Air shares are owned by insiders. Comparatively, 19.0% of BrainsWay shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

BrainsWay beats Beyond Air on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWAY vs. The Competition

MetricBrainsWaySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$163.96M$4.42B$5.06B$8.82B
Dividend YieldN/A41.17%5.17%4.07%
P/E Ratio98.3124.81125.9917.81
Price / Sales5.1647.011,180.3874.38
Price / CashN/A51.8733.8232.53
Price / Book3.934.974.684.68
Net Income-$4.20M$13.76M$119.54M$226.08M
7 Day Performance8.74%-3.09%-2.45%-2.04%
1 Month Performance-2.29%0.22%-4.06%0.06%
1 Year Performance103.94%42.64%29.86%24.60%

BrainsWay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BWAY
BrainsWay
3.9884 of 5 stars
$9.83
+1.7%
$13.17
+33.9%
+103.9%$161.28M$31.78M98.31120Gap Up
XAIR
Beyond Air
4.5392 of 5 stars
$0.49
-5.8%
$3.67
+645.9%
-69.1%$37.87M$1.16M0.0070Gap Down
DCTH
Delcath Systems
3.5248 of 5 stars
$9.63
-2.8%
$21.50
+123.3%
+256.7%$316.86M$2.07M0.0076
APEN
Apollo Endosurgery
N/AN/AN/AN/A$579.72M$76.86M-9.80202
KIDS
OrthoPediatrics
4.0997 of 5 stars
$25.50
+4.9%
$40.00
+56.9%
-19.9%$588.93M$148.73M-20.73200
AXGN
AxoGen
2.7099 of 5 stars
$12.90
+1.2%
$15.00
+16.3%
+113.2%$561.10M$159.01M0.00426
SIBN
SI-BONE
4.3736 of 5 stars
$12.15
-1.4%
$23.00
+89.3%
-32.6%$516.68M$138.89M0.00350Analyst Forecast
Insider Trade
Analyst Revision
TMCI
Treace Medical Concepts
1.0224 of 5 stars
$7.98
+2.8%
$7.40
-7.3%
-7.1%$483.42M$187.12M0.00250
CATX
Perspective Therapeutics
2.7597 of 5 stars
$6.16
-9.1%
$21.57
+250.2%
N/A$458.24M$1.43M0.00116Analyst Revision
TCMD
Tactile Systems Technology
3.7846 of 5 stars
$15.56
-1.3%
$23.00
+47.8%
+23.1%$378.43M$274.42M23.94980
ZIMV
ZimVie
2.5824 of 5 stars
$13.49
+2.4%
$18.33
+35.9%
+49.2%$363.48M$457.43M0.002,600

Related Companies and Tools


This page (NASDAQ:BWAY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners